Mid Cap
Biological Products, Except Diagnostic Substances
Stocks Ranked by
Market Capitalization
Filters
# | Name | Market cap | Price | Price change % | |
---|---|---|---|---|---|
1 | $9.51B | $33.29 | -1.16% | ||
2 | $8.14B | $44.06 | +1.78% | ||
3 | $8.09B | $144.46 | -1.42% | ||
4 | $5.97B | $46.96 | -0.76% | ||
5 | $4.74B | $164.83 | +2.49% | ||
6 | $4.19B | $44.78 | +6.39% | ||
7 | $4.11B | $17.40 | -2.79% | ||
8 | $4.08B | $75.54 | +0.44% | ||
9 | $3.8B | $25.86 | +0.78% | ||
10 | $3.48B | $40.72 | +0.82% | ||
11 | $3.09B | $21.45 | -0.19% | ||
12 | $2.85B | $47.94 | +9.9% | ||
13 | $2.79B | $56.50 | +2.82% | ||
14 | $2.71B | $47.71 | +1.47% | ||
15 | $2.65B | $35.59 | +2.33% | ||
16 | $2.63B | $40.66 | +3.88% | ||
17 | $2.4B | $29.01 | +8.04% | ||
18 | $2.36B | $6.03 | -0.99% | ||
19 | $2.25B | $7.38 | +2.22% | ||
20 | $2.18B | $28.67 | +2.32% | ||
21 | $2.02B | $52.91 | +1.75% |